Dietary folate intake and fecundability in two preconception cohorts.

cohort study dietary folate fecundability folic acid supplementation preconception pregnancy planners

Journal

Human reproduction (Oxford, England)
ISSN: 1460-2350
Titre abrégé: Hum Reprod
Pays: England
ID NLM: 8701199

Informations de publication

Date de publication:
01 04 2022
Historique:
received: 26 07 2021
revised: 28 11 2021
pubmed: 21 1 2022
medline: 5 4 2022
entrez: 20 1 2022
Statut: ppublish

Résumé

To what extent is dietary folate intake and total folate intake (dietary and supplemental intakes) associated with fecundability, the per cycle probability of conception? Preconception dietary folate intake was positively associated with fecundability in a monotonic pattern. Supplemental folic acid has been associated with improved fertility, but little is known about the relation between dietary folate and fecundability. A prospective cohort study including 9559 women trying to conceive without fertility treatment and enrolled in the period 2013-2020. We used data from two internet-based prospective cohort studies of pregnancy planners from Denmark, where folic acid fortification is not performed (SnartForældre.dk (SF); n = 3755) and North America, where the food supply is fortified with folic acid (Pregnancy Study Online (PRESTO); n = 5804). Women contributed menstrual cycles at risk until they reported conception or experienced a censoring event. We used proportional probabilities regression models to compute fecundability ratios (FRs) and 95% CI, adjusting for potential confounders. Compared with a dietary folate intake ≥400 µg/day, the adjusted FRs for women in SF were 0.92 (95% CI: 0.85-0.99) for intake 250-399 µg/day, and 0.80 (95% CI: 0.68-0.94) for intake of <250 µg/day. The corresponding FRs in PRESTO were 0.95 (95% CI: 0.89-1.01) and 0.81 (95% CI: 0.65-1.00). Compared with the highest level of total folate intake (diet folate ≥400 µg/day plus folic acid supplementation), in both cohorts fecundability was lowest among women with the lowest dietary intake <250 µg/day dietary folate and no supplementation (FR: 0.76, 95% CI: 0.59-0.98 [SF] and 0.49, 95% CI: 0.31-0.77 [PRESTO]). Further, total intake dietary folate <250 µg/day plus supplementation was associated with reduced fecundability for SF participants (FR; 0.79, 95% CI: 0.65-0.98) and for PRESTO participants (FR; 0.92, 95% CI: 0.72-1.16). It is unknown whether dietary folate and folic acid intake affect fecundability on its own or if there is an interaction with other micronutrients provided in healthy diet. Thus, the observed associations may not reflect dietary folate intake alone, but overall healthy diet. Recommendations for preconception dietary folate intake and folic acid supplementation are of importance not only to prevent neural tube defects but also to enhance fecundability. The study was supported by the National Institute of Child Health and Human Development (R01-HD086742). The authors report no competing interests. N/A.

Identifiants

pubmed: 35051293
pii: 6512239
doi: 10.1093/humrep/deac002
pmc: PMC8971647
doi:

Substances chimiques

Folic Acid 935E97BOY8

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

828-837

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD086742
Pays : United States

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

J Nutr. 2014 Mar;144(3):399-407
pubmed: 24453128
Am J Obstet Gynecol. 2018 Apr;218(4):379-389
pubmed: 28844822
Int J Vitam Nutr Res. 1996;66(1):55-8
pubmed: 8698547
Nutr Rev. 2010 Feb;68(2):99-113
pubmed: 20137055
PLoS One. 2012;7(9):e46276
pubmed: 23050004
Fertil Steril. 2008 Jun;89(6):1766-70
pubmed: 17923130
J Nutr. 2022 Feb 8;152(2):492-500
pubmed: 34224563
Am J Epidemiol. 1989 May;129(5):1072-8
pubmed: 2705427
Obstet Gynecol. 2014 Oct;124(4):801-809
pubmed: 25198264
J Nutr. 2009 Aug;139(8):1549-54
pubmed: 19549759
Obes Facts. 2017;10(6):674-693
pubmed: 29237159
Eur J Nutr. 2019 Jun;58(4):1475-1493
pubmed: 29594476
Am J Epidemiol. 2001 Dec 15;154(12):1089-99
pubmed: 11744511
Clin Exp Obstet Gynecol. 2006;33(4):205-8
pubmed: 17211965
Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504
pubmed: 10993420
Ginekol Pol. 2003 Oct;74(10):1392-6
pubmed: 14669450
Stat Med. 2001 May 15-30;20(9-10):1541-9
pubmed: 11343373
Nutrients. 2011 Mar;3(3):370-84
pubmed: 22254102
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Public Health Nutr. 2016 Apr;19(6):1027-34
pubmed: 26235206
Hum Reprod Update. 2008 Jul-Aug;14(4):345-57
pubmed: 18535004
Am J Epidemiol. 2003 Jul 1;158(1):1-13
pubmed: 12835280
Paediatr Perinat Epidemiol. 2013 Sep;27(5):491-502
pubmed: 23930785
Fertil Steril. 2008 Mar;89(3):668-76
pubmed: 17624345
BMJ. 2016 Aug 31;354:i4262
pubmed: 27581754
Adv Nutr. 2012 Jan;3(1):21-38
pubmed: 22332098
Paediatr Perinat Epidemiol. 2015 Jul;29(4):360-71
pubmed: 26111445
Rev Obstet Gynecol. 2011 Summer;4(2):52-9
pubmed: 22102928
Clin Epidemiol. 2017 Mar 15;9:157-166
pubmed: 28352203
Hum Reprod. 2009 Sep;24(9):2293-302
pubmed: 19443458
Am J Epidemiol. 2006 Feb 1;163(3):279-88
pubmed: 16339051
Hum Reprod Update. 2007 Mar-Apr;13(2):163-74
pubmed: 17099205
Public Health Nutr. 2016 May;19(7):1168-83
pubmed: 26354204
J Nutr. 1999 Apr;129(4):779-82
pubmed: 10203550
Int J Epidemiol. 2009 Aug;38(4):938-43
pubmed: 18782897
Eur J Clin Nutr. 2016 Jan;70(1):66-71
pubmed: 26081493
Nutrients. 2020 Jul 29;12(8):
pubmed: 32751290
Compr Rev Food Sci Food Saf. 2016 May;15(3):506-528
pubmed: 33401816
Am J Clin Nutr. 1997 Apr;65(4 Suppl):1220S-1228S; discussion 1229S-1231S
pubmed: 9094926
JAMA. 2017 Jan 10;317(2):183-189
pubmed: 28097362
Am J Epidemiol. 1977 Sep;106(3):184-7
pubmed: 900117
Am J Epidemiol. 2007 Feb 15;165(4):444-52
pubmed: 17150983
Nutr Rev. 1998 Oct;56(10):294-9
pubmed: 9810807
Eur J Epidemiol. 2010 May;25(5):297-304
pubmed: 20148289

Auteurs

Heidi T Cueto (HT)

The Danish Clinical Quality Program and National Clinical Registries (RKKP), Aarhus, Denmark.
Department of Clinical Epidemiology, Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.

Bjarke H Jacobsen (BH)

Department of Clinical Epidemiology, Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.

Anne Sofie Dam Laursen (ASD)

Department of Clinical Epidemiology, Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.

Anders H Riis (AH)

Department of Clinical Epidemiology, Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.

Elizabeth E Hatch (EE)

Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.

Lauren A Wise (LA)

Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.

Ellen Trolle (E)

National Food Institute, Technical University of Denmark, Kgs Lyngby, Denmark.

Henrik Toft Sørensen (HT)

Department of Clinical Epidemiology, Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.

Kenneth J Rothman (KJ)

Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.
RTI International, Research Triangle Park, NC, USA.

Amelia K Wesselink (AK)

Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.

Sydney Willis (S)

Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.

Benjamin R Johannesen (BR)

Department of Clinical Epidemiology, Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.

Ellen M Mikkelsen (EM)

Department of Clinical Epidemiology, Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH